HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New designed HMBA agents as inducers of erythroleukemia cell differentiation.

AbstractOBJECTIVE:
Searching for more potent and less toxic HMBA-related agents.
METHODS:
Human erythroleukemia cell K562, murine erythroleukemia cell (MEL) and its sub-line MEL DS19 were used as target cells to select a cell line which is the most sensitive to HMBA, then analyzed the activity of inducing differentiation of two new designed HMBA derivatives: HMBPA [hexamethylenebi (3-pyridin) amide] and Co-HDTA (ethylenediaminetetra acetic acid cobalt) using cell biology, cytochemical and molecular biology techniques.
RESULTS:
We found that the MEL DS19 cells were most sensitive to HMBA (benzidine positive, B+ approximately 76%). Co-HDTA can inhibit the growth of MEL DS19, but induces differentiation just in a small population (B+ 2% approximately 4.5%). Between 0.02 approximately 5 micromol/L, HMBPA induces 3% approximately 8% cells committed to differentiation with little inhibition of cell proliferation. 1 micromol/L HMBPA and 2 mmol/L HMBA together, can obviously increase the percentage of differentiated cell (B+ approximately 72%), inhibit DNA synthesis and accelerate beta-globin transcription.
CONCLUSION:
The new HMBA derivatives may provide potential cancer differentiation inducers.
AuthorsHuali Wang, Shifu Zhang, Jianping Zhou, Jingbo Zhang
JournalChinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih (Chin Med Sci J) Vol. 17 Issue 1 Pg. 27-31 (Mar 2002) ISSN: 1001-9294 [Print] China
PMID12894881 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetamides
  • Antineoplastic Agents
  • Pyridines
  • RNA, Messenger
  • hexamethylenebi (3-pyridin) amide
  • Globins
  • hexamethylene bisacetamide
Topics
  • Acetamides (chemistry, pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Cell Differentiation (drug effects)
  • Cell Division (drug effects)
  • Globins (biosynthesis, genetics)
  • Humans
  • K562 Cells
  • Leukemia, Erythroblastic, Acute (metabolism, pathology)
  • Mice
  • Pyridines (chemistry, pharmacology)
  • RNA, Messenger (genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: